-
-
Call more information
660-596-2224 -
Author: Ana Maria Crawford, MD, MSc, FASA ASA Monitor January 2023, Vol. 87, 30. CRITICAL CARE Abstract Millions of people die each year from sepsis and septic shock. Sepsis is defined as life-threatening organ dysfunction caused by a dysregulated host response to infection (JAMA 2016;315:801-10). The Surviving Sepsis Campaign (SSC) formed in 2002 as a joint […]
Read MoreAUTHORS: Connie Chung, MD et al Anesthesia Patient Safety Foundation Volume 38, No. 2 • June 2023 The American Society of Anesthesiologists (ASA) Committee on Practice Parameters (CPP), chaired by Karen Domino, MD, MPH, created a task force to develop guidelines for neuromuscular blockade (NMB) to improve patient safety and satisfaction. The Anesthesia Patient Safety Foundation […]
Read MoreAuthors: Zachary Deutch, MD, FASA; Bryan D. Laliberte, MD, FASA ASA Monitor January 2023, Vol. 87, 1–11. Dr. Laliberte placing a chest tube on an injured Iraqi soldier with the assistance of emergency medicine physician Dr. Jillian Phelps in our ED/triage tent. Happy 2023 to all, and thank you for joining us for a very special column. […]
Read MoreAuthors: Richard Simoneaux; Steven L. Shafer, MD, FASA ASA Monitor January 2023, Vol. 87, 1–8. During the first two years of the pandemic, SARS-CoV-2 steadily evolved. The ancestral Wuhan strain gave way to the Alpha variant, followed by Beta, Gamma, and Delta variants, each more infectious than the last (ASA Monitor 2021;85:1-7). A year ago, the ultra-infectious […]
Read MoreAuthor: Hannah Viroslav, BA, MD ASA Monitor January 2023, Vol. 87, 35. The style of medical writing that residents are exposed to, both in medical school and throughout training, revolves around the many. We are taught to think in terms of evidence-based medicine – and with evidence, the power is in the numbers. Most literally, a […]
Read MoreAuthors:Hasushita, Yudai MD et al A & A Practice 16(9):p e01616, September 2022. Remimazolam is a recently approved benzodiazepine sedative. We report a case of a 72-year-old man who experienced a cardiac arrest due to severe anaphylaxis immediately after general anesthesia induction. Based on the results of skin tests, including those for dextran 40, an […]
Read MoreAuthors: Nicholas L. McKenzie, B.S.P.H. et al Anesthesiology January 2023, Vol. 138, 42–54. Background Perioperative β-blocker therapy has been associated with increased risk of stroke. However, the association between β-blocker initiation before the day of surgery and the risk of stroke is unknown. The authors hypothesized there would be no association between preoperative β-blocker initiation within […]
Read MoreAuthor: Paul Pomerantz, FACHE ASA Monitor January 2023, Vol. 87, 12. Happy New Year! As I write this, it is mid-November, and I am always amazed at how quickly the end of year comes upon us. At ASA, it is a busy time: annual meeting reconciliation and follow-up, membership renewals, performance reviews, end-of-year accounting, implementation of […]
Read MoreAuthors: Heather Lander, MD; et al ASA Monitor January 2023, Vol. 87, 20–21. According to a recent World Health Organization (WHO) publication, in 2020 the number of people aged 60 years and older outnumbered children younger than 5 years worldwide (asamonitor.pub/3NC2L83). Simultaneous to the rapidly growing older population, their surgical and perioperative needs are also increasing. […]
Read MoreAuthor: Mariah Taylor Becker’s Hospital Review A recent study found risk-adjusted survival rates for cardiac arrest can vary as much as 71 percent between two randomly chosen hospitals. The study, published Dec. 15 in JACC Cardiovascular Interventions, analyzed 4,787 patients from 231 hospitals. The median survival rate was 36 percent, but the rates varied from 20 percent to […]
Read More